Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis.
Autor(a) principal: | |
---|---|
Data de Publicação: | 2005 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/11018 |
Resumo: | Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil / Federal University of Maranhão. UFMA. Department of Nursing. São Luís, MA, Brasil |
id |
CRUZ_3bf6bf2fc7fbed0eff146dc1d2011c8f |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/11018 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Caldas, Arlene de Jesus MendesFavali, Cecilia Beatriz FiuzaAquino, Dorlene Maria Cardoso deVinhas, Vera Silvia de FreitasVan Weyenbergh, Johan Jozef Rosa MariaBrodskyn, Claudia IdaCosta, Jackson Mauricio LopesBarral Netto, ManoelBarral, Aldina Maria Prado2015-06-30T17:07:14Z2015-06-30T17:07:14Z2005CALDAS, A. J. M. et al. Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. BMC Infectious Diseases, v. 5, p. 113, 2005.1471-2334https://www.arca.fiocruz.br/handle/icict/1101810.1186/1471-2334-5-113engBioMed CentralBalance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis.info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil / Federal University of Maranhão. UFMA. Department of Nursing. São Luís, MA, BrasilFundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, BrasilFundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil / Federal University of Maranhão. UFMA. Department of Nursing. São Luís, MA, BrasilFundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, BrasilFundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil / 4Institute of Investigation in Immunology. Salvador, BA, BrasilFundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil / 4Institute of Investigation in Immunology. Salvador, BA, BrasilFundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, BrasilFundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, BrasilFundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, BrasilBACKGROUND: Leishmaniasis remains a serious public health problem in several parts of the developing world. Effective prophylactic measurements are hampered by imprecise comprehension of different aspects of the disease, including its immunoregulation. A better comprehension of immunoregulation in human VL may be useful both for designing and evaluating immunoprophylaxis. METHODS: To explore immunoregulatory mechanisms, 20 visceral leishmaniasis (VL) patients were evaluated during active disease and at different periods up to one year after treatment determining their plasma cytokine levels, clinical parameters (palpable spleen and liver) and antibody levels. RESULTS: Elevated plasma levels of IFN-gamma and of IL-12 p40 were observed during active disease, significantly decreasing after treatment whereas in vitro Leishmania antigen-stimulated IFN-gamma production by PBMC exhibited an inverse pattern being low during disease and increasing steadily thereafter. Absence of IFN-gamma activity is a hallmark of VL. The main candidate for blunting IFN-gamma activity is IL-10, a cytokine highly elevated in plasma with sharp decrease after treatment. Activity of IL-10 is inferred by high levels of anti-Leishmania specific IgG1 and IgG3. TGF-beta had elevated total, but not of active, levels lessening the likelihood of being the IFN-gamma counterpart. Spleen or liver size presented a steady decrease but return to normal values at only 120 days after treatment. Anti-Leishmania IgG (total and subclasses) levels and DTH or Leishmania-stimulated lymphocyte proliferation conversion to positive also present a slow decrease after treatment. IL-6 plasma levels were elevated in only a few patients. CONCLUSION: Taken together our results suggest that IFN-gamma and IL-10 are the molecules most likely involved in determining fate of disease. After treatment, there is a long delay before the immune profile returns to normal what precludes using plasma cytokine levels as criteria of cure as simpler clinical evaluations, as a palpable spleen or liver, can be used.Interferon gama/sangueInterleucina-10/sangueLeishmaniose Visceral/sangueLeishmaniose Visceral/fisiopatologiaAdolescenteAdultoAntiprotozoários/uso terapêuticoPré-EscolarCriançaFemininoHumanosLactenteInterferon gama/imunologiaInterleucina-10/imunologiaLeishmaniose Visceral/quimioterapiaFígado/patologiaMasculinoMeglumina/uso terapêuticoMeia-IdadeTamanho do ÓrgãoCompostos Organometálicos/uso terapêuticoBaço/patologiainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82354https://www.arca.fiocruz.br/bitstream/icict/11018/1/license.txt8b4c200b4e10021c5683c6ccaba07169MD51ORIGINALCaldas A Balance of IL-10 and interferon.......pdfCaldas A Balance of IL-10 and interferon.......pdfapplication/pdf716910https://www.arca.fiocruz.br/bitstream/icict/11018/2/Caldas%20%20A%20%20%20Balance%20of%20IL-10%20and%20interferon.......pdf97412173b494bcb490cb197c3fb217c9MD52TEXTCaldas A Balance of IL-10 and interferon.......pdf.txtCaldas A Balance of IL-10 and interferon.......pdf.txtExtracted texttext/plain38491https://www.arca.fiocruz.br/bitstream/icict/11018/3/Caldas%20%20A%20%20%20Balance%20of%20IL-10%20and%20interferon.......pdf.txtcd0a635853e72faafa27655827a681d4MD53icict/110182023-03-15 14:32:58.04oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:32:58Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. |
title |
Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. |
spellingShingle |
Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. Caldas, Arlene de Jesus Mendes Interferon gama/sangue Interleucina-10/sangue Leishmaniose Visceral/sangue Leishmaniose Visceral/fisiopatologia Adolescente Adulto Antiprotozoários/uso terapêutico Pré-Escolar Criança Feminino Humanos Lactente Interferon gama/imunologia Interleucina-10/imunologia Leishmaniose Visceral/quimioterapia Fígado/patologia Masculino Meglumina/uso terapêutico Meia-Idade Tamanho do Órgão Compostos Organometálicos/uso terapêutico Baço/patologia |
title_short |
Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. |
title_full |
Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. |
title_fullStr |
Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. |
title_full_unstemmed |
Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. |
title_sort |
Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. |
author |
Caldas, Arlene de Jesus Mendes |
author_facet |
Caldas, Arlene de Jesus Mendes Favali, Cecilia Beatriz Fiuza Aquino, Dorlene Maria Cardoso de Vinhas, Vera Silvia de Freitas Van Weyenbergh, Johan Jozef Rosa Maria Brodskyn, Claudia Ida Costa, Jackson Mauricio Lopes Barral Netto, Manoel Barral, Aldina Maria Prado |
author_role |
author |
author2 |
Favali, Cecilia Beatriz Fiuza Aquino, Dorlene Maria Cardoso de Vinhas, Vera Silvia de Freitas Van Weyenbergh, Johan Jozef Rosa Maria Brodskyn, Claudia Ida Costa, Jackson Mauricio Lopes Barral Netto, Manoel Barral, Aldina Maria Prado |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Caldas, Arlene de Jesus Mendes Favali, Cecilia Beatriz Fiuza Aquino, Dorlene Maria Cardoso de Vinhas, Vera Silvia de Freitas Van Weyenbergh, Johan Jozef Rosa Maria Brodskyn, Claudia Ida Costa, Jackson Mauricio Lopes Barral Netto, Manoel Barral, Aldina Maria Prado |
dc.subject.decs.pt_BR.fl_str_mv |
Interferon gama/sangue Interleucina-10/sangue Leishmaniose Visceral/sangue Leishmaniose Visceral/fisiopatologia Adolescente Adulto Antiprotozoários/uso terapêutico Pré-Escolar Criança Feminino Humanos Lactente Interferon gama/imunologia Interleucina-10/imunologia Leishmaniose Visceral/quimioterapia Fígado/patologia Masculino Meglumina/uso terapêutico Meia-Idade Tamanho do Órgão Compostos Organometálicos/uso terapêutico Baço/patologia |
topic |
Interferon gama/sangue Interleucina-10/sangue Leishmaniose Visceral/sangue Leishmaniose Visceral/fisiopatologia Adolescente Adulto Antiprotozoários/uso terapêutico Pré-Escolar Criança Feminino Humanos Lactente Interferon gama/imunologia Interleucina-10/imunologia Leishmaniose Visceral/quimioterapia Fígado/patologia Masculino Meglumina/uso terapêutico Meia-Idade Tamanho do Órgão Compostos Organometálicos/uso terapêutico Baço/patologia |
description |
Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil / Federal University of Maranhão. UFMA. Department of Nursing. São Luís, MA, Brasil |
publishDate |
2005 |
dc.date.issued.fl_str_mv |
2005 |
dc.date.accessioned.fl_str_mv |
2015-06-30T17:07:14Z |
dc.date.available.fl_str_mv |
2015-06-30T17:07:14Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
CALDAS, A. J. M. et al. Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. BMC Infectious Diseases, v. 5, p. 113, 2005. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/11018 |
dc.identifier.issn.none.fl_str_mv |
1471-2334 |
dc.identifier.doi.none.fl_str_mv |
10.1186/1471-2334-5-113 |
identifier_str_mv |
CALDAS, A. J. M. et al. Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. BMC Infectious Diseases, v. 5, p. 113, 2005. 1471-2334 10.1186/1471-2334-5-113 |
url |
https://www.arca.fiocruz.br/handle/icict/11018 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
BioMed Central |
publisher.none.fl_str_mv |
BioMed Central |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/11018/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/11018/2/Caldas%20%20A%20%20%20Balance%20of%20IL-10%20and%20interferon.......pdf https://www.arca.fiocruz.br/bitstream/icict/11018/3/Caldas%20%20A%20%20%20Balance%20of%20IL-10%20and%20interferon.......pdf.txt |
bitstream.checksum.fl_str_mv |
8b4c200b4e10021c5683c6ccaba07169 97412173b494bcb490cb197c3fb217c9 cd0a635853e72faafa27655827a681d4 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813009096726544384 |